• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant Pharmaceuticals

Valeant Pharmaceuticals

Page 3 of 4
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant Shareholders Push for More Details About CEO’s Illness
By ReutersMarch 13, 2016
NCAA Men's Final Four - Championship
FeaturesFed Meeting, Valeant Earnings, and March Madness—5 Things to Know for the Week Ahead
By Tom Huddleston Jr.March 13, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthBill Ackman Just Got Himself a Board Member on Valeant
By ReutersMarch 9, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s Why Shares of Valeant Are Jumping Today
By ReutersMarch 7, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
FinanceThis Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up
By Jen WiecznerMarch 4, 2016
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
FinanceValeant Is Being Investigated by the SEC and Shares Are Plunging
By Dan PrimackFebruary 29, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceThis Is Why Shares of Valeant Are Cratering Today
By Lucinda ShenFebruary 29, 2016
House Oversight Hearing On Prescription Drug Price Increases
FinanceWhy Valeant’s Stock Surged After CEO Admitted ‘Mistakes’
By Jen WiecznerFebruary 23, 2016
Views From A Shoppers Drug Mart Store Ahead Of Earns
HealthStudy Says This Cold Medicine Doesn’t Actually Fight Colds
By Michal AddadyFebruary 1, 2016
Inside The 2016 Consumer Electronics Show
FinanceThese Stock Market-Battered Execs Just Became Ex-Billionaires
By Robert HackettJanuary 26, 2016
High Oil Prices Continue To Drive Gas Prices Steadily Upwards
HealthDoomsday Postponed and Valeant’s Management Talks–5 Things to Know Today
By Laura Lorenzetti and Geoffrey SmithJanuary 13, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant CEO Says Board Is ‘Welcome to Fire Me’
By Jen WiecznerDecember 16, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceCongressman Calls Out Valeant’s ‘Lack of Transparency’
By Laura LorenzettiDecember 16, 2015
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
FinanceNovartis Agrees to $390 Million Settlement
By Jen WiecznerNovember 20, 2015
RetailWhy the drug price scandal won’t be enough to keep down prices
By Laura LorenzettiOctober 26, 2015
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Gen Z’s straight‑A boom is quietly shrinking their paychecksAn image of a popular article
By Fortune EditorsMarch 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.